CAS: 23138-64-9; 3-Acetylphenylisocyanate

该化合物是一种活性有机化合物,其特点是存在一个异氰酸盐组(-NCO)和芳香环上的乙酰替代物.这一结构使该化合物成为尿素,氨基甲酸盐和其他异氰酸盐化合物合成中的宝贵中间体.其高反应性能够有效地融入聚合物,药物和农用化学.乙酰基组提高了溶性,并提供了一个进一步功能化的场所,扩大了其在有机合成中的用途.该化合物通常在受控制的条件下处理,原因是异氰酸盐组的湿度敏感.它通常用于需要精确分子设计的研究和工业应用中.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号99-03-6 3'-氨基苯乙酮 | CAS号503-38-8 氯甲酸三氯甲酯 | CAS号86764-52-5 3-(3-acetylphen... | CAS号86781-34-2 3-(3-acetylphen...

合成工艺路线路线简述

    三光气,间氨基苯乙酮 以 四氢呋喃 用作溶剂,化学反应 3.5H,反应生成异氰酸3-乙酰基苯酯
    参考文献:含5-氟吲哚-2-酮部分的苯脲的设计,合成及抗肿瘤评估
    标题:含5-氟吲哚-2-酮部分的苯脲的设计,合成及抗肿瘤评估
    摘要:背景:新型抗肿瘤药的开发仍然非常需要. 目的:本研究的重点是带有5-氟吲哚-2-酮部分的苯基脲的设计,合成和抗肿瘤评估. 方法:设计并合成了三套苯基脲,并通过mtt法测定了它们对四种人类癌细胞系(hela,Eca-109,A549和mcf-7)的抗增殖能力.在人乳腺癌的异种移植模型(mcf-7)中进一步评估了体内抗癌活性. 结果:总共合成了二十一种新化合物,并通过1H和13C NMR以及hr-Ms进行了表征.最初构建了三组化合物(1A‒1C,2A‒2C和3A‒3C),并评估了这些分子对hela,Eca-109,A549和mcf-7的初步抗增殖活性,突出了间位取代的苯基脲(1A‒1C)是最具细胞毒性的药物.然后设计并合成了一系列间位取代的苯基脲衍生物(1D‒1O)用于结构-活性关系研究.大多数新化合物显示出理想的细胞毒性,其中化合物1G对测试的人类癌细胞表现出最显着的细胞毒性作用,Ic50值为1
    Doi:10.2174/1573406416666200206123319

    海关参考信息

    专利信息


    专利号:US-5877278-A
    优先权日:1992-09-24
    标题:Synthesis of N-substituted oligomers
    发明人:ZUCKERMANN RONALD N; GOFF DANE A; NG SIMON; SPEAR KERRY; SCOTT BARBARA O; SIGMUND AARON C; GOLDSMITH RICHARD A; MARLOWE CHARLES K; PEI YAZHONG; RICHTER LUTZ; SIMON REYNA
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a solid support-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability. Combinatorial libraries of cyclic compounds are disclosed wherein the cyclic compounds are comprised of at least one ring structure derived from cyclization of a peptoid backbone. The diversity of product compounds is generated by the sequential addition of substituted submonomers. The combinatorial library includes 10 or more, preferably 100 or more, and more preferably 1,000 or more distinct and different compounds. The library includes each of the product compounds in retrievable and analyzable amounts and preferably includes at least one biologically active compound. Methods of synthesizing the combinatorial libraries and assay devices produced using the libraries are disclosed as is methodology for screening for and obtaining biologically active cyclic organic compounds.

    专利号:WO-9700244-A1
    优先权日:1995-06-19
    标题 :Process for parallel synthesis of a non-peptide library
    发明人:FRITZ JAMES E; KALDOR STEPHEN W
    权利人:LILLY CO ELI; FRITZ JAMES E; KALDOR STEPHEN W
    摘要:A process for the sequential preparation of a library of compounds having pharmaceutical usage. The process involves the sequential mixing of solution phase reagents, followed by scavenging of excess unreacted reagents with solid phase scavenging agents. The process is highly iterative and applicable for producing various ureas, thiureas, amides, carbonates and tertiary amines.

    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-2022010060-A1
    优先权日:2018-12-12
    标题:Polycarbonate polyols
    发明人:FENG XIAOSHUANG; PATIL NAGANATH; BOOPATHI Senthil; GNANOU YVES; HADJICHRISTIDIS NIKOS
    权利人:UNIV KING ABDULLAH SCI & TECH
    摘要:Embodiments of the present disclosure describe polymerization systems for the synthesis of polycarbonate polyols, methods of synthesizing polycarbonate polyols using the polymerization systems, methods of recovering initiators and/or activators for use or re-use in the synthesis of polycarbonate polyol, and the like. The polymerization systems can comprise an initiator including a mono- or multi-functional carboxylate or carbonate salt having an organic cation as a counter-ion; an optional co-initiator including a mono- or multi-functional protic compound selected from acids, alcohols, water, and combinations thereof; and an activator including a borane compound selected from alkyl boranes and aryl boranes; wherein the activator and one or more of the initiator and co-initiator associate to form an ate complex.

    专利号:EP-0789577-A1
    优先权日:1995-06-07
    标 题:Synthesis of n-substituted oligomers
    河南氢硅新材料科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.qgxcl.com
    企业联系电话:18569915792(微信号15038032370);18039286726(微信同号)👤
    📞河南氢硅新材料科技有限公司 ⚠️参考联系方式

    电话:18569915792(微信号15038032370);18039286726(微信同号)


    邮箱:qingguixincailiao@163.com
    通信地址: 河南省焦作市沁阳市沁园街道未来路1号
    邮编: 454550
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:河南省焦作市沁阳市沁园街道未来路1号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知